FDA approves new flu shot using recombinant DNA technology

The following is an excerpt.

A new flu shot, Flublok, made using new technology, has just been approved by the U.S. FDA (Food and Drug Administration). Flublok is the first trivalent influenza vaccine made using an insect virus (baculovirus) expression system and recombinant DNA technology. Currently, the flu is quickly spreading across the United States. Public health officials have said the flu is now at “epidemic levels”. The CDC (Centers for Disease Control and Prevention) advises everyone to receive a flu shot before the upcoming flu season.